BKHA in +1.78% Uptrend, advancing for three consecutive days on September 01, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BKHA advanced for three days, in 9 of 26 cases, the price rose further within the following month. The odds of a continued upward trend are 35%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 09, 2026. You may want to consider a long position or call options on BKHA as a result. In 9 of 29 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 31%.
The Moving Average Convergence Divergence (MACD) for BKHA just turned positive on August 26, 2026. Looking at past instances where BKHA's MACD turned positive, the stock continued to rise in 9 of 28 cases over the following month. The odds of a continued upward trend are 32%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BKHA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 11%.
The Aroon Indicator for BKHA entered a downward trend on September 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. BKHA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.464) is normal, around the industry mean (2.669). P/E Ratio (99.917) is within average values for comparable stocks, (165.550). BKHA's Dividend Yield (0.000) is considerably lower than the industry average of (0.034). P/S Ratio (0.000) is also within normal values, averaging (1.790).
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BKHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.